Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Operating Income: 2012-2025

Historic Operating Income for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $22.9 million.

  • Veracyte's Operating Income rose 90.95% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 205.17%. This contributed to the annual value of $16.1 million for FY2024, which is 118.81% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Operating Income is $22.9 million, which was up 535.57% from -$5.3 million recorded in Q2 2025.
  • Veracyte's 5-year Operating Income high stood at $22.9 million for Q3 2025, and its period low was -$45.4 million during Q1 2021.
  • Its 3-year average for Operating Income is -$4.5 million, with a median of -$4.7 million in 2024.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 555.11% in 2023, then spiked by 162.37% in 2025.
  • Quarterly analysis of 5 years shows Veracyte's Operating Income stood at -$12.3 million in 2021, then spiked by 56.05% to -$5.4 million in 2022, then crashed by 555.11% to -$35.5 million in 2023, then skyrocketed by 111.76% to $4.2 million in 2024, then spiked by 90.95% to $22.9 million in 2025.
  • Its last three reported values are $22.9 million in Q3 2025, -$5.3 million for Q2 2025, and $2.9 million during Q1 2025.